Orphan Drug Pricing: An Original Exponential Model Relating Price to the Number of Patients
In managing drug prices at the national level, orphan drugs represent a special case because the price of these agents is higher than that determined according to value-based principles. A common practice is to set the orphan drug price in an inverse relationship with the number of patients, so that...
Saved in:
Main Author: | Andrea Messori (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2016-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The impact of early phase price agreements on prices of orphan drugs
by: Mark Nuijten, et al.
Published: (2021) -
Pricing of orphan drugs in oncology and rare diseases
by: Mark Nuijten, et al.
Published: (2020) -
A comparative study of orphan drug prices in Europe
by: Katherine Eve Young, et al.
Published: (2017) -
Orphan drugs' clinical uncertainty and prices: Addressing allocative and technical inefficiencies in orphan drug reimbursement
by: Hans-Georg Eichler, et al.
Published: (2023) -
Negotiating Medical Insurance Drug Prices: The Role in Reducing Costs of Orphan Drugs for Rare Diseases
by: Jinmiao Lu, et al.
Published: (2023)